Divyya, Shree <br/><br/>
GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.  [electronic resource] 

 -  Molecular biology reports  Oct 2013 
 - 5541-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-4978 
<br/><br/><label>Standard No.: </label>10.1007/s11033-013-2655-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, Surface--metabolism<br/>Biomarkers, Tumor--metabolism<br/>Case-Control Studies<br/>DNA Methylation--genetics<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Predisposition to Disease<br/>Glutamate Carboxypeptidase II--metabolism<br/>Glutathione--blood<br/>Glutathione S-Transferase pi--genetics<br/>Humans<br/>Male<br/>Malondialdehyde--blood<br/>Membrane Proteins--genetics<br/>Middle Aged<br/>Nitrites--blood<br/>Oxidative Stress--genetics<br/>Prostatic Neoplasms--blood<br/>Proto-Oncogene Proteins--genetics<br/>ROC Curve<br/>Superoxide Dismutase--metabolism<br/>Tumor Suppressor Proteins--genetics